Skip to content

Comparison of TOFscan and TOF-Watch SX in Pediatric Neuromuscular Function Recovery

Comparison of TOFscan and TOF-Watch SX in Children

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03775603
Enrollment
37
Registered
2018-12-14
Start date
2019-03-02
Completion date
2020-01-30
Last updated
2020-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuromuscular Blockade

Brief summary

Comparison of TOFscan and TOF-Watch SX for monitoring of neuromuscular blockade function in children

Detailed description

TOF ratio of TOFscan when TOF-Watch SX shows TOF ratio 0.7 with rocuronium in children during general anesthesia

Interventions

DEVICETOFscan

comparison of TOFscan over TOF-Watch SX

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 12 Years
Healthy volunteers
No

Inclusion criteria

* patients need neuromuscular blockade

Exclusion criteria

* contraindication of rocuronium

Design outcomes

Primary

MeasureTime frameDescription
TOF ratio of TOFscanintraoperative during anesthesiavalue of TOF ratio of TOFscan at TOF ratio 0.7 of TOF-Watch SX during neuromuscular function recovery period

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026